Eli Lilly Invests Over $1B In Seamless’ Gene-Editing Hearing Loss Treatments

_linkedin_partner_id = "8637721"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); (function(l) { if (!l){window.lintrk = function(a,b){window.lintrk.q.push([a,b])}; window.lintrk.q=[]} var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(window.lintrk); <img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=8637721&fmt=gif" />